BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37195109)

  • 1. [Salivary gland cancer: new therapeutic approaches].
    Herrera Gomez RG; Mederos N; Szturz P; Degrauwe N; Jankovic J; Cristina V
    Rev Med Suisse; 2023 May; 19(827):958-963. PubMed ID: 37195109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Molecular Testing in the Differential Diagnosis of Salivary Gland Carcinomas.
    Skálová A; Stenman G; Simpson RHW; Hellquist H; Slouka D; Svoboda T; Bishop JA; Hunt JL; Nibu KI; Rinaldo A; Vander Poorten V; Devaney KO; Steiner P; Ferlito A
    Am J Surg Pathol; 2018 Feb; 42(2):e11-e27. PubMed ID: 29076877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salivary Gland Cancers.
    Tchekmedyian V
    Hematol Oncol Clin North Am; 2021 Oct; 35(5):973-990. PubMed ID: 34503735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salivary gland carcinoma: Towards a more personalised approach.
    Rached L; Saleh K; Casiraghi O; Even C
    Cancer Treat Rev; 2024 Mar; 124():102697. PubMed ID: 38401478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequent PTEN loss and differential HER2/PI3K signaling pathway alterations in salivary duct carcinoma: Implications for targeted therapy.
    Saintigny P; Mitani Y; Pytynia KB; Ferrarotto R; Roberts DB; Weber RS; Kies MS; Maity SN; Lin SH; El-Naggar AK
    Cancer; 2018 Sep; 124(18):3693-3705. PubMed ID: 30289966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A molecular guide to systemic therapy in salivary gland carcinoma.
    Weaver AN; Lakritz S; Mandair D; Ulanja MB; Bowles DW
    Head Neck; 2023 May; 45(5):1315-1326. PubMed ID: 36859797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic therapy for salivary gland malignancy: current status and future perspectives.
    Imamura Y; Kiyota N; Tahara M; Hanai N; Asakage T; Matsuura K; Ota I; Saito Y; Sano D; Kodaira T; Motegi A; Yasuda K; Takahashi S; Yokota T; Okano S; Tanaka K; Onoe T; Ariizumi Y; Homma A
    Jpn J Clin Oncol; 2022 Apr; 52(4):293-302. PubMed ID: 35134985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salivary duct carcinomas can be classified into luminal androgen receptor-positive, HER2 and basal-like phenotypes.
    Di Palma S; Simpson RH; Marchiò C; Skálová A; Ungari M; Sandison A; Whitaker S; Parry S; Reis-Filho JS
    Histopathology; 2012 Oct; 61(4):629-43. PubMed ID: 22882517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular signature of salivary gland tumors: potential use as diagnostic and prognostic marker.
    Fonseca FP; Sena Filho M; Altemani A; Speight PM; Vargas PA
    J Oral Pathol Med; 2016 Feb; 45(2):101-10. PubMed ID: 25990369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole-Genome Sequencing of Common Salivary Gland Carcinomas: Subtype-Restricted and Shared Genetic Alterations.
    Karpinets TV; Mitani Y; Liu B; Zhang J; Pytynia KB; Sellen LD; Karagiannis DT; Ferrarotto R; Futreal AP; El-Naggar AK
    Clin Cancer Res; 2021 Jul; 27(14):3960-3969. PubMed ID: 34011559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SalvGlandDx - a comprehensive salivary gland neoplasm specific next generation sequencing panel to facilitate diagnosis and identify therapeutic targets.
    Freiberger SN; Brada M; Fritz C; Höller S; Vogetseder A; Horcic M; Bihl M; Michal M; Lanzer M; Wartenberg M; Borner U; Bode PK; Broglie MA; Rordorf T; Morand GB; Rupp NJ
    Neoplasia; 2021 May; 23(5):473-487. PubMed ID: 33878706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of tumour profiling on clinical trials in salivary gland cancer.
    Rack S; Rahman R; Carter L; McKay C; Metcalf R
    Clin Otolaryngol; 2019 Jan; 44(1):1-6. PubMed ID: 30102009
    [No Abstract]   [Full Text] [Related]  

  • 13. Adenoid cystic carcinomas of the salivary gland, lacrimal gland, and breast are morphologically and genetically similar but have distinct microRNA expression profiles.
    Andreasen S; Tan Q; Agander TK; Steiner P; Bjørndal K; Høgdall E; Larsen SR; Erentaite D; Olsen CH; Ulhøi BP; von Holstein SL; Wessel I; Heegaard S; Homøe P
    Mod Pathol; 2018 Aug; 31(8):1211-1225. PubMed ID: 29467480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenoid cystic carcinomas of the breast and salivary glands (or 'The strange case of Dr Jekyll and Mr Hyde' of exocrine gland carcinomas).
    Marchiò C; Weigelt B; Reis-Filho JS
    J Clin Pathol; 2010 Mar; 63(3):220-8. PubMed ID: 20203221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-grade Transformation/Dedifferentiation in Salivary Gland Carcinomas: Occurrence Across Subtypes and Clinical Significance.
    Skalova A; Leivo I; Hellquist H; Agaimy A; Simpson RHW; Stenman G; Vander Poorten V; Bishop JA; Franchi A; Hernandez-Prera JC; Slouka D; Willems SM; Olsen KD; Ferlito A
    Adv Anat Pathol; 2021 May; 28(3):107-118. PubMed ID: 33825717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Novel therapeutic approaches for salivary gland carcinomas].
    Nachtsheim L; Prinz J; Arolt C; Quaas A; Meyer M; Klußmann JP; Wolber P
    Laryngorhinootologie; 2022 Nov; 101(11):876-881. PubMed ID: 35320850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human epidermal growth factor receptor 2 (HER2) in salivary gland carcinomas.
    Clauditz TS; Reiff M; Gravert L; Gnoss A; Tsourlakis MC; Münscher A; Sauter G; Bokemeyer C; Knecht R; Wilczak W
    Pathology; 2011 Aug; 43(5):459-64. PubMed ID: 21670724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CDK12 alterations and ARID1A mutations are predictors of poor prognosis and therapeutic targets in high-grade salivary gland carcinoma: analysis of the National Genomic Profiling Database.
    Kobayashi K; Saito Y; Kage H; Fukuoka O; Yamamura K; Mukai T; Oda K; Yamasoba T
    Jpn J Clin Oncol; 2023 Aug; 53(9):798-807. PubMed ID: 37357968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic profiling of breast secretory carcinomas reveals distinct genetics from other breast cancers and similarity to mammary analog secretory carcinomas.
    Krings G; Joseph NM; Bean GR; Solomon D; Onodera C; Talevich E; Yeh I; Grenert JP; Hosfield E; Crawford ED; Jordan RC; van Zante A; Zaloudek C; Shin SJ; Chen YY
    Mod Pathol; 2017 Aug; 30(8):1086-1099. PubMed ID: 28548128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [MicroRNA-profiling in breast- and salivary gland-derived adenoid cystic carcinomas].
    Kiss O; Tőkés AM; Spisák S; Szilágyi A; Lippai N; Szász AM; Kulka J
    Orv Hetil; 2013 Jun; 154(25):963-8. PubMed ID: 23774803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.